Richtlijnen en literatuur

Richtlijnen

Klik HIER voor de richtlijn 'AL-amyloïdose' van de HOVON Myeloom werkgroep.

Literatuur  

1. Sanchorawala V. Systemic light chain amyloidosis. N Engl J Med 2024; 390:2295-2307
2. Kumar S et al. Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. J Clin Oncol. 2012; 30:989-95
3. Buxbaum JN et al. Amyloid nomenclature 2022: update, novel proteins and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid 2022; 29:213-219
4. Palladini G et al. A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis. Blood. 2014; 124:2325-32
5. Palladini G et al. Clarification on the definition of complete haematologic response in light-chain (AL) amyloidosis. Amyloid 2021; 28:1-2
6. Muchtar et al. Graded cardiac response criteria for patients with systemic light chain amyloidosis. J Clin Oncol 2023; 41:1393-1403
7. Kastritis E et al. Daratumumab-based treatment for immunoglobulin light-chain amyloidosis. N Engl J Med 2021; 385:46-58
8. Website www.amyloid.nl

Ga terug naar de AL-amyloïdose homepage of lees meer over AL-amyloïdose:

• Inleiding
• Diagnostiek
• Classificatie
• Risicoclassificatie
• Behandeling
• Respons criteria
• Follow up
• Beheer en wijzigingenhistorie

Ga terug naar de algemene homepage Behandelprotocollen.